PubMed

Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus.

Fowler VG Jr, Boucher HW, Corey GR, Abrutyn E, Karchmer AW, Rupp ME, Levine DP, Chambers HF, Tally FP, Vigliani GA, Cabell CH, Link AS, DeMeyer I, Filler SG, Zervos M, Cook P, Parsonnet J, Bernstein JM, Price CS, Forrest GN, Fätkenheuer G, Gareca M, Rehm SJ, Brodt HR, Tice A, Cosgrove SE; S. aureus Endocarditis and Bacteremia Study Group.

N Engl J Med. 2006 Aug 17;355(7):653-65.PMID: 16914701 [PubMed - indexed for MEDLINE]Related articlesFree article

Daptomycin: a novel agent for Gram-positive infections.

Tally FP, Zeckel M, Wasilewski MM, Carini C, Berman CL, Drusano GL, Oleson FB Jr.

Expert Opin Investig Drugs. 1999 Aug;8(8):1223-38.PMID: 15992147 [PubMed]Related articles

Daptomycin: a lipopeptide antibiotic for the treatment of serious Gram-positive infections.

Steenbergen JN, Alder J, Thorne GM, Tally FP.

J Antimicrob Chemother. 2005 Mar;55(3):283-8. Epub 2005 Feb 10. Review.PMID: 15705644 [PubMed - indexed for MEDLINE]Related articlesFree article

The importance of bactericidal drugs: future directions in infectious disease.

Finberg RW, Moellering RC, Tally FP, Craig WA, Pankey GA, Dellinger EP, West MA, Joshi M, Linden PK, Rolston KV, Rotschafer JC, Rybak MJ.

Clin Infect Dis. 2004 Nov 1;39(9):1314-20. Epub 2004 Oct 7. Review.PMID: 15494908 [PubMed - indexed for MEDLINE]Related articles

The safety and efficacy of daptomycin for the treatment of complicated skin and skin-structure infections.

Arbeit RD, Maki D, Tally FP, Campanaro E, Eisenstein BI; Daptomycin 98-01 and 99-01 Investigators.

Clin Infect Dis. 2004 Jun 15;38(12):1673-81. Epub 2004 May 20.PMID: 15227611 [PubMed - indexed for MEDLINE]Related articles

Once-daily dosing in dogs optimizes daptomycin safety.

Oleson FB Jr, Berman CL, Kirkpatrick JB, Regan KS, Lai JJ, Tally FP.

Antimicrob Agents Chemother. 2000 Nov;44(11):2948-53.PMID: 11036005 [PubMed - indexed for MEDLINE]Related articlesFree article

Development of daptomycin for gram-positive infections.

Tally FP, DeBruin MF.

J Antimicrob Chemother. 2000 Oct;46(4):523-6. Review. No abstract available. PMID: 11020247 [PubMed - indexed for MEDLINE]Related articlesFree article

Drug target validation: lethal infection blocked by inducible peptide.

Tao J, Wendler P, Connelly G, Lim A, Zhang J, King M, Li T, Silverman JA, Schimmel PR, Tally FP.

Proc Natl Acad Sci U S A. 2000 Jan 18;97(2):783-6.PMID: 10639157 [PubMed - indexed for MEDLINE]Related articlesFree article

Researchers reveal ways to defeat 'superbugs'

Tally FP.

Drug Discov Today. 1999 Sep;4(9):395-398. No abstract available. PMID: 10461147 [PubMed - as supplied by publisher]Related articles

Antimicrobial resistance in anaerobes.

Rasmussen BA, Bush K, Tally FP.

Clin Infect Dis. 1997 Jan;24 Suppl 1:S110-20. Review.PMID: 8994790 [PubMed - indexed for MEDLINE]Related articles

Inhibition of protein synthesis occurring on tetracycline-resistant, TetM-protected ribosomes by a novel class of tetracyclines, the glycylcyclines.

Rasmussen BA, Gluzman Y, Tally FP.

Antimicrob Agents Chemother. 1994 Jul;38(7):1658-60.PMID: 7526784 [PubMed - indexed for MEDLINE]Related articlesFree article

Glycylcyclines. 1. A new generation of potent antibacterial agents through modification of 9-aminotetracyclines.

Sum PE, Lee VJ, Testa RT, Hlavka JJ, Ellestad GA, Bloom JD, Gluzman Y, Tally FP.

J Med Chem. 1994 Jan 7;37(1):184-8.PMID: 8289194 [PubMed - indexed for MEDLINE]Related articles

In vitro and in vivo antibacterial activities of the glycylcyclines, a new class of semisynthetic tetracyclines.

Testa RT, Petersen PJ, Jacobus NV, Sum PE, Lee VJ, Tally FP.

Antimicrob Agents Chemother. 1993 Nov;37(11):2270-7.PMID: 8285606 [PubMed - indexed for MEDLINE]Related articlesFree article

Antimicrobial resistance in Bacteroides.

Rasmussen BA, Bush K, Tally FP.

Clin Infect Dis. 1993 Jun;16 Suppl 4:S390-400. Review.PMID: 8324154 [PubMed - indexed for MEDLINE]Related articles

Safety profile of piperacillin/tazobactam in phase I and III clinical studies.

Kuye O, Teal J, DeVries VG, Morrow CA, Tally FP.

J Antimicrob Chemother. 1993 Jan;31 Suppl A:113-24.PMID: 8383652 [PubMed - indexed for MEDLINE]Related articles

Antibiotic resistance. Epidemiology and therapeutics.

Neu HC, Duma RJ, Jones RN, McGowan JE Jr, O'Brien TF, Sabath LD, Sanders CC, Schaffner W, Tally FP, Tenover FC, et al.

Diagn Microbiol Infect Dis. 1992 Feb;15(2 Suppl):53S-60S. No abstract available. PMID: 1737445 [PubMed - indexed for MEDLINE]Related articles

Molecular basis of tetracycline action: identification of analogs whose primary target is not the bacterial ribosome.

Rasmussen B, Noller HF, Daubresse G, Oliva B, Misulovin Z, Rothstein DM, Ellestad GA, Gluzman Y, Tally FP, Chopra I.

Antimicrob Agents Chemother. 1991 Nov;35(11):2306-11.PMID: 1725100 [PubMed - indexed for MEDLINE]Related articlesFree article

Microbiology and antibiotic resistance in odontogenic infections.

Gorbach SL, Gilmore WC, Jacobus NV, Doku HC, Tally FP.

Ann Otol Rhinol Laryngol Suppl. 1991 Sep;154:40-2. No abstract available. PMID: 1952683 [PubMed - indexed for MEDLINE]Related articles

Escherichia coli chromosomal mutations that permit direct cloning of the Bacteroides fragilis metallo-beta-lactamase gene, ccrA.

Rasmussen BA, Gluzman Y, Tally FP.

Mol Microbiol. 1991 May;5(5):1211-9.PMID: 1956298 [PubMed - indexed for MEDLINE]Related articles

R-plasmid mediated transfer of beta-lactam resistance in Bacteroides fragilis.

Yamaoka K, Watanabe K, Muto Y, Katoh N, Ueno K, Tally FP.

J Antibiot (Tokyo). 1990 Oct;43(10):1302-6.PMID: 2258328 [PubMed - indexed for MEDLINE]Related articles

Cloning and sequencing of the class B beta-lactamase gene (ccrA) from Bacteroides fragilis TAL3636.

Rasmussen BA, Gluzman Y, Tally FP.

Antimicrob Agents Chemother. 1990 Aug;34(8):1590-2.PMID: 2121094 [PubMed - indexed for MEDLINE]Related articlesFree article

Candidal meningitis following bacterial meningitis.

Gelfand MS, McGee ZA, Kaiser AB, Tally FP, Moses J.

South Med J. 1990 May;83(5):567-70.PMID: 2188372 [PubMed - indexed for MEDLINE]Related articles

Comparative activities of newer beta-lactam agents against members of the Bacteroides fragilis group.

Cuchural GJ Jr, Tally FP, Jacobus NV, Cleary T, Finegold SM, Hill G, Iannini P, O'Keefe JP, Pierson C.

Antimicrob Agents Chemother. 1990 Mar;34(3):479-80.PMID: 2334161 [PubMed - indexed for MEDLINE]Related articlesFree article

Imipenem resistance in Bacteroides distasonis mediated by a novel beta-lactamase.

Hurlbut S, Cuchural GJ, Tally FP.

Antimicrob Agents Chemother. 1990 Jan;34(1):117-20.PMID: 2327745 [PubMed - indexed for MEDLINE]Related articlesFree article

In-vitro susceptibility of the Bacteroides fragilis group and the inoculum effect of newer beta-lactam antibiotics on this group of organisms.

Jacobus NV, Cuchural GJ Jr, Tally FP.

J Antimicrob Chemother. 1989 Nov;24(5):675-82.PMID: 2599992 [PubMed - indexed for MEDLINE]Related articles

Synergistic activity of piperacillin: YTR-830H combinations in vitro and in vivo.

Kuck NA, Petersen PJ, Weiss WJ, Jacobus NV, Testa RT, Tally FP.

J Chemother. 1989 Jul;1(4 Suppl):105-6. No abstract available. PMID: 16312325 [PubMed - indexed for MEDLINE]Related articles

Recurrent tonsillitis: histologic and bacteriologic evaluation.

Bieluch VM, Martin ET, Chasin WD, Tally FP.

Ann Otol Rhinol Laryngol. 1989 May;98(5 Pt 1):332-5.PMID: 2719449 [PubMed - indexed for MEDLINE]Related articles

Permeability to beta-lactams in Bacteroides fragilis.

Cuchural GJ, Hurlbut S, Malamy MH, Tally FP.

J Antimicrob Chemother. 1988 Dec;22(6):785-90.PMID: 3266619 [PubMed - indexed for MEDLINE]Related articles

A prospective double-blind evaluation of penicillin versus clindamycin in the treatment of odontogenic infections.

Gilmore WC, Jacobus NV, Gorbach SL, Doku HC, Tally FP.

J Oral Maxillofac Surg. 1988 Dec;46(12):1065-70.PMID: 3142979 [PubMed - indexed for MEDLINE]Related articles

Antibiotic resistance in anaerobic bacteria.

Tally FP, Cuchural GJ Jr.

J Antimicrob Chemother. 1988 Jul;22 Suppl A:63-71.PMID: 3264832 [PubMed - indexed for MEDLINE]Related articles

Factors affecting the choice of antibiotics in mixed infections.

Tally FP.

J Antimicrob Chemother. 1988 Jul;22 Suppl A:87-100.PMID: 3209540 [PubMed - indexed for MEDLINE]Related articles

Susceptibility of the Bacteroides fragilis group in the United States: analysis by site of isolation.

Cuchural GJ Jr, Tally FP, Jacobus NV, Aldridge K, Cleary T, Finegold SM, Hill G, Iannini P, O'Keefe JP, Pierson C, et al.

Antimicrob Agents Chemother. 1988 May;32(5):717-22.PMID: 3395102 [PubMed - indexed for MEDLINE]Related articlesFree article

Activity of trospectomycin against Bacteroides fragilis and other Bacteroides species.

Jacobus NV, Tally FP.

Antimicrob Agents Chemother. 1988 Apr;32(4):584-6.PMID: 2967671 [PubMed - indexed for MEDLINE]Related articlesFree article

Prospective study comparing imipenem-cilastatin with clindamycin and gentamicin for the treatment of serious surgical infections.

Hackford AW, Tally FP, Reinhold RB, Barza M, Gorbach SL.

Arch Surg. 1988 Mar;123(3):322-6.PMID: 3277587 [PubMed - indexed for MEDLINE]Related articles

Antimicrobial resistance in oral and colonic bacteroides.

Crook DW, Cuchural GJ Jr, Jacobus NV, Tally FP.

Scand J Infect Dis Suppl. 1988;57:55-64. Review.PMID: 3074473 [PubMed - indexed for MEDLINE]Related articles

Comparative efficacy of clindamycin, erythromycin and spiramycin against Staphylococcus aureus in the rat croton oil pouch model.

Davey PG, Jacobus NV, Tally FP.

J Antimicrob Chemother. 1987 Nov;20(5):705-12.PMID: 3429372 [PubMed - indexed for MEDLINE]Related articles

Cryptic tetracycline resistance determinant (class F) from Bacteroides fragilis mediates resistance in Escherichia coli by actively reducing tetracycline accumulation.

Park BH, Hendricks M, Malamy MH, Tally FP, Levy SB.

Antimicrob Agents Chemother. 1987 Nov;31(11):1739-43.PMID: 3324960 [PubMed - indexed for MEDLINE]Related articlesFree article

Safety profile of cefixime.

Tally FP, Desjardins RE, McCarthy EF, Cartwright K.

Pediatr Infect Dis J. 1987 Oct;6(10):976-80.PMID: 3320926 [PubMed - indexed for MEDLINE]Related articles

Clinical importance of cefoxitin-resistant Bacteroides fragilis isolates.

Bieluch VM, Cuchural GJ, Snydman DR, Gorbach SL, Tally FP.

Diagn Microbiol Infect Dis. 1987 Jun;7(2):119-26.PMID: 3652652 [PubMed - indexed for MEDLINE]Related articles

Management of patients with intraabdominal infection due to colonic perforation.

Tally FP, Ho JL.

Curr Clin Top Infect Dis. 1987;8:266-95. Review. No abstract available. PMID: 3077280 [PubMed - indexed for MEDLINE]Related articles

Beta-lactamase-mediated imipenem resistance in Bacteroides fragilis.

Cuchural GJ Jr, Malamy MH, Tally FP.

Antimicrob Agents Chemother. 1986 Nov;30(5):645-8.PMID: 3492173 [PubMed - indexed for MEDLINE]Related articlesFree article

In-vitro activity of cefoperazone-sulbactam against Bacteroides species.

Souza Dias MB, Jacobus NV, Tally FP.

J Antimicrob Chemother. 1986 Oct;18(4):467-71.PMID: 3021709 [PubMed - indexed for MEDLINE]Related articles

Bacteroides fragilis: current susceptibilities, mechanisms of drug resistance, and principles of antimicrobial therapy.

Cuchural GJ Jr, Tally FP.

Drug Intell Clin Pharm. 1986 Jul-Aug;20(7-8):567-73.PMID: 3488895 [PubMed - indexed for MEDLINE]Related articles

Bacteriology of hospital-acquired pneumonia.

Bartlett JG, O'Keefe P, Tally FP, Louie TJ, Gorbach SL.

Arch Intern Med. 1986 May;146(5):868-71.PMID: 3516102 [PubMed - indexed for MEDLINE]Related articles

Transfer of beta-lactamase-associated cefoxitin resistance in Bacteroides fragilis.

Cuchural GJ Jr, Tally FP, Storey JR, Malamy MH.

Antimicrob Agents Chemother. 1986 May;29(5):918-20.PMID: 3488018 [PubMed - indexed for MEDLINE]Related articlesFree article

Activity of cefotetan against anaerobic bacteria.

Dias MB, Jacobus NV, Tally FP, Gorbach SL.

Diagn Microbiol Infect Dis. 1986 Apr;4(4):359-63.PMID: 3457672 [PubMed - indexed for MEDLINE]Related articles

Randomized prospective study comparing moxalactam and cefoxitin with or without tobramycin for the treatment of serious surgical infections.

Tally FP, Kellum JM, Ho JL, O'Donnell TF, Barza M, Gorbach SL.

Antimicrob Agents Chemother. 1986 Feb;29(2):244-9.PMID: 3717931 [PubMed - indexed for MEDLINE]Related articlesFree article

Resistance factors in anaerobic bacteria.

Tally FP, Malamy MH.

Scand J Infect Dis Suppl. 1986;49:56-63. Review.PMID: 3029859 [PubMed - indexed for MEDLINE]Related articles

Tn4400, a compound transposon isolated from Bacteroides fragilis, functions in Escherichia coli.

Robillard NJ, Tally FP, Malamy MH.

J Bacteriol. 1985 Dec;164(3):1248-55.PMID: 2999075 [PubMed - indexed for MEDLINE]Related articlesFree article

Nationwide study of the susceptibility of the Bacteroides fragilis group in the United States.

Tally FP, Cuchural GJ Jr, Jacobus NV, Gorbach SL, Aldridge K, Cleary T, Finegold SM, Hill G, Iannini P, O'Keefe JP, et al.

Antimicrob Agents Chemother. 1985 Nov;28(5):675-7.PMID: 4091530 [PubMed - indexed for MEDLINE]Related articlesFree article